Results 181 to 190 of about 11,507,104 (364)

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

New England Journal of Medicine, 2017
Louise Bowman, J. Hopewell, Fang Chen, K. Wallendszus, W. Stevens, R. Collins, S. Wiviott, Christopher P. Cannon, E. Braunwald, E. Sammons, M. Landray   +10 more
semanticscholar   +1 more source

Some Aspects of Obliterative Vascular Disease of the Lower Limb [PDF]

, 1962
Michael E. DeBakey
openalex   +2 more sources

Editorial: Diabetes augmentation on vascular disease, volume II. [PDF]

Front Cardiovasc Med
Reardon CA, Getz GS.
europepmc   +1 more source

Two New Diseases attacking the Vascular Bundles of Tomato Fruits and Radish Roots

, 1941
Hiromu OKAMOTO
openalex   +2 more sources

Behcet's disease with retinal vascular lesions. [PDF]

, 1967
Rhodri Smith, Ian A. Prior, D Sturman
openalex   +1 more source

3D (Bio) Printing Combined Fiber Fabrication Methods for Tissue Engineering Applications: Possibilities and Limitations

Advanced Functional Materials, EarlyView.
Biofabrication aims at providing innovative technologies and tools for the fabrication of tissue‐like constructs for tissue engineering and regenerative medicine applications. By integrating multiple biofabrication technologies, such as 3D (bio) printing with fiber fabrication methods, it would be more realistic to reconstruct native tissue's ...
Waseem Kitana, Indra Apsite, Leonid Ionov   +2 more
wiley   +1 more source

A role for proteoglycans in vascular disease.

Matrix Biology, 2018
T. Wight
semanticscholar   +1 more source

Evaluation of Lipoprotein(a) as a Prognostic Marker of Extracoronary Atherosclerotic Vascular Disease Progression. [PDF]

Circulation
Bellomo TR, Bramel EE, Lee J, Urbut S, Flores A, Yu Z, Koyama S, Truong B, Haidermota S, Eagleton MJ, Natarajan P, Patel AP.   +11 more
europepmc   +1 more source

Versatile Cell Penetrating Peptide for Multimodal CRISPR Gene Editing in Primary Stem Cells

Advanced Functional Materials, EarlyView.
CRISPR machinery in diverse molecular formats (DNA, RNA, and ribonucleic protein) is complexed into nanoparticles with the cell‐friendly arginine‐alanine‐leucine‐alanine (RALA) cell‐penetrating peptide. Nanoparticles are delivered to primary mesenchymal stem cells ex vivo or locally in vivo to facilitate multimodal CRISPR gene editing. This RALA‐CRISPR
Joshua P. Graham, Jose Gabriel Castro, Lisette C. Werba, Joseph Amitrano, Luke Fardone, Kevin P. Francis, Anand Ramamurthi, Michael J. Layden, Helen O. McCarthy, Tomas Gonzalez‐Fernandez   +9 more
wiley   +1 more source

Prognosis for Patients with Ventricular Septal Defect and Severe Pulmonary Vascular Obstructive Disease [PDF]

, 1968
P. M. Clarkson, Robert L. Frye, James W. DuShane, Howard B. Burchell, Earl H. Wood, William H. Weidman   +5 more
openalex   +1 more source